On 3 February, the members of the PREDICTFTD Public Involvement Board (PREDICTFTD-PIB) gathered online for a consultation to review a nasal swab leaflet that researchers developed for the participants of the PREDICTFTD study. During the consultation, the members of the PREDICTFTD-PIB were shown the draft leaflet and provided insightful feedback to improve it and making it more accessible and understandable. This consultation was attended and facilitated by Soraya Moradi-Bachiller, Public Involvement Officer at Alzheimer Europe.
The PREDICTFTD project was launched in December 2024, funded by the EU’s Horizon Europe programme for a period of 4.5 years. The project, which includes partners from 8 countries, is developing biomarkers and tools to advance the diagnosis of FTD, aiming to reduce the time it takes to obtain an accurate, biological diagnosis of the condition.
